Summit Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Summit Financial Group's MRK Position: Q1 2024 in Review
Summit Financial Group reduced its Merck (MRK) stake by 2.9% in Q1 2024, selling an estimated $25.9K and leaving 7,044 shares worth $929K. The position accounts for 0.33% of the portfolio, ranked #88.
Summit Financial Group first reported a position in MRK in Q2 2017 and has held it in 28 quarters since. The position peaked at $1.15M in Q3 2017. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Summit Financial Group held 7,044 shares of Merck worth $929K as of Q1 2024.
- Summit Financial Group sold 210 Merck shares in Q1 2024, an estimated $25.9K.
- Merck made up 0.33% of Summit Financial Group's portfolio in Q1 2024, its #88 holding.
- Summit Financial Group first reported a position in Merck in Q2 2017 and has held it in 28 quarters since.
- Summit Financial Group's Merck position peaked at $1.15M in Q3 2017.
- 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.